An error was identified in the HEDIS MY 2024 Medication List Directory (released on April 1, 2024). For the Asthma Medication Ratio (AMR) measure, “package size” and “unit” are required to perform calculations. If we cannot find package size and unit for NDC codes, we cannot include the codes in the AMR medication lists. For the MY 2024 Update release of the MLD, an alternative method was used to identify package size and unit so more codes could be included in the medication lists. Because this method resulted in incorrect information, we removed these codes from 11 medication lists.
- Albuterol Medications
- Asthma Controller and Reliever Medications
- Beclomethasone Medications
- Budesonide Formoterol Medications
- Budesonide Medications
- Ciclesonide Medications
- Fluticasone Medications
- Fluticasone Salmeterol Medications
- Formoterol Mometasone Medications
- Levalbuterol Medications
- Mometasone Medications
Three medication lists were removed from the AMR measure.
- Fluticasone Furoate Umeclidinium Vilanterol Medications
- Salmeterol Medications
- Tiotropium Medications
Customers who purchased the HEDIS MY 2024 Medication List Directory should re-download the file from the My Downloads section of their My NCQA account. Customers who purchased a product that contains the AMR measure specification should delete the three medication lists, consistent with how changes from the technical update are applied.
HEDIS MY 2024